Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
46
MD Quote, Financials, Valuation and Earnings
Last price:
$19.86
Seasonality move
:
-3.02%
Day range:
$19.41 - $19.86
52-week range:
$11.84 - $24.99
Dividend yield:
0%
P/E ratio:
10.25x
P/S ratio:
0.88x
P/B ratio:
1.97x
Volume:
883.1K
Avg. volume:
817.4K
1-year change:
31.81%
Market cap:
$1.7B
Revenue:
$1.9B
EPS (TTM):
$1.94
Analysts' Opinion
-
Consensus RatingPediatrix Medical Group, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $21.33, Pediatrix Medical Group, Inc. has an estimated upside of 7.42% from its current price of $19.85.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $19.00 representing 4.33% downside risk from its current price of $19.85.
Fair Value
-
According to the consensus of 7 analysts, Pediatrix Medical Group, Inc. has 7.42% upside to fair value with a price target of $21.33 per share.
MD vs. S&P 500
-
Over the past 5 trading days, Pediatrix Medical Group, Inc. has overperformed the S&P 500 by 2.91% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Pediatrix Medical Group, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Pediatrix Medical Group, Inc. revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Pediatrix Medical Group, Inc. reported revenues of $493.8M.
Earnings Growth
-
Pediatrix Medical Group, Inc. has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Pediatrix Medical Group, Inc. reported earnings per share of $0.40.
Enterprise value:
1.8B
EV / Invested capital:
1.23x
Price / LTM sales:
0.88x
EV / EBIT:
7.96x
EV / Revenue:
0.96x
PEG ratio (5yr expected):
-0.66x
EV / Free cash flow:
7.28x
Price / Operating cash flow:
6.70x
Enterprise value / EBITDA:
7.28x
Gross Profit (TTM):
$471.9M
Return On Assets:
7.73%
Net Income Margin (TTM):
8.64%
Return On Equity:
19.95%
Return On Invested Capital:
11.19%
Operating Margin:
11.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $2B | $2B | $1.9B | $502.4M | $493.8M | |
| Gross Profit | $385.4M | $422.1M | $471.9M | $121.7M | $120.4M | |
| Operating Income | $157.9M | $183.7M | $231.1M | $58.1M | $54.7M | |
| EBITDA | $194M | $215.9M | $252.9M | $65M | $60.3M | |
| Diluted EPS | -$0.73 | -$1.20 | $1.94 | $0.36 | $0.40 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $840.6M | $428M | $483.5M | $639.6M | $763.5M | |
| Total Assets | $2.7B | $2.3B | $2.2B | $2.2B | $2.2B | |
| Current Liabilities | $427.4M | $427M | $388.9M | $434.1M | $458.9M | |
| Total Liabilities | $1.8B | $1.5B | $1.4B | $1.4B | $1.4B | |
| Total Equity | $896.7M | $891.6M | $849.1M | $764.9M | $865.9M | |
| Total Debt | $1B | $695.5M | $680.6M | $649.6M | $623M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $137.3M | $206.6M | $271.1M | $133M | $114.1M | |
| Cash From Investing | -$48.2M | -$35.4M | -$18.3M | -$1.9M | -$10.3M | |
| Cash From Financing | -$25.7M | -$14.5M | -$107.5M | -$5M | -$68.6M | |
| Free Cash Flow | $104M | $184.6M | $252.6M | $129.6M | $108.8M | |
MD
Sector
Market Cap
$1.7B
$25.8M
Price % of 52-Week High
79.47%
50.24%
Dividend Yield
0%
0%
Shareholder Yield
5.08%
-1.64%
1-Year Price Total Return
32.4%
-18.88%
Beta (5-Year)
0.759
0.496
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$19.94
200-day SMA
Buy
Level
$17.81
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$20.68
Relative Strength Index (RSI14)
Sell
Level
41.39
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-45.5487
50-day SMA
Sell
Level
$21.37
MACD (12, 26)
Sell
Level
-0.47
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
--
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1003)
Buy
CA Score
(Annual)
Level (-0.2436)
Buy
Beneish M-Score
(Annual)
Level (-2.8732)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.4606)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Pediatrix Medical Group, Inc. engages in the provision of physician services. Its services include neonatal care, maternal fetal care, and other pediatric subspeciality care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.
Stock Forecast FAQ
In the current month, MD has received 2 Buy ratings 5 Hold ratings, and 0 Sell ratings. The MD average analyst price target in the past 3 months is $21.33.
-
Where Will Pediatrix Medical Group, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Pediatrix Medical Group, Inc. share price will rise to $21.33 per share over the next 12 months.
-
What Do Analysts Say About Pediatrix Medical Group, Inc.?
Analysts are divided on their view about Pediatrix Medical Group, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Pediatrix Medical Group, Inc. is a Sell and believe this share price will drop from its current level to $19.00.
-
What Is Pediatrix Medical Group, Inc.'s Price Target?
The price target for Pediatrix Medical Group, Inc. over the next 1-year time period is forecast to be $21.33 according to 7 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is MD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Pediatrix Medical Group, Inc. is a Hold. 5 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MD?
You can purchase shares of Pediatrix Medical Group, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Pediatrix Medical Group, Inc. shares.
-
What Is The Pediatrix Medical Group, Inc. Share Price Today?
Pediatrix Medical Group, Inc. was last trading at $19.86 per share. This represents the most recent stock quote for Pediatrix Medical Group, Inc.. Yesterday, Pediatrix Medical Group, Inc. closed at $19.85 per share.
-
How To Buy Pediatrix Medical Group, Inc. Stock Online?
In order to purchase Pediatrix Medical Group, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get MD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MD
Sector
P/E ratio
10.25x
23.44x
PEG ratio
-0.66x
-0.01x
P/B ratio
1.97x
1.81x
Price / LTM sales
0.88x
1.56x
Growth Metrics
MD
Sector
Revenue growth
-1.71%
3.27%
Earnings growth
12.39%
9.66%
Revenue (5-year growth)
1.99%
6.43%
Earnings forecast
$0.54
-$0.20
Profitability
MD
Sector
Profitability FY 2025
$471.9M
$2.3M
Return on invested capital
11.19%
-33.49%
Return on assets
7.73%
-29.74%
Return on equity
19.95%
-39.33%
Earnings Date
Last Earnings Date
Feb
19
Next Earnings Date
May
5
Estimated Next Earnings Date
May
21
Balance Sheet
MD
Sector
Total cash
$499.7M
$24.2M
Short term investments
$118.6M
$23.8M
Total assets
$2.2B
$71.1M
Long term debt
$623M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
39
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
54
AAOI alert for Feb 28
Applied Optoelectronics, Inc. [AAOI] is up 56.96% over the past day.
Buy
90
BNAI alert for Feb 28
Brand Engagement Network, Inc. [BNAI] is up 36.02% over the past day.
Buy
59
SEZL alert for Feb 27
Sezzle, Inc. [SEZL] is down 13.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
